LKFT · Lakefront Biotherapeutics NV
Market Cap
$1.92B
Shares
65.48M
Volume · Oct 2
270.23K
Avg daily vol (3M)
253.28K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$29.37
Open$28.94
Day$28.88–29.44
52W close$26.08–37.62
Avg vol 30d289K
Short int3.4M · 5.2% float · 12.4d
Short vol58%
Last earningsNov 11, 2026
DataJan 2020–Oct 2026
Up next
Next earnings call
Nov 11, 2026
Scheduled
· in 5 wks
call held Feb 24, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-18.1%
Trailing year
Short interest
5.2%
Latest settlement · 12.4 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Moderate
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−3%
below
Price vs 50-day avg
+4%
above
RSI (14)
53
neutral
MACD trend
Positive
52-week position
29%
mid-range
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+3%
trailing
YTD return
−10%
this year
Relative strength
−9%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $28 › 200d $30 — 200d above 50d
Institutional flow
Accumulating
1 of 76 funds reported for Sep 30 · net +1.0K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
5.21% of float · ▲ +3.6% MoM · 12.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
76 holders — near 3-yr low, contrarian setup
Squeeze score
63
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
30%
annualized · 1-yr
Max drawdown
−31%
past year
ATR
2.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Dec 31, 2020
Jyseleca contribution margin
· second half of this decade
50%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−3%
Neutral
Price vs 50-day avg
+4%
Bullish
RSI (14)
53
Neutral
MACD trend
Positive
Bullish
52-week position
29%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $28 › 200d $30 — 200d above 50d
Institutional flow
Accumulating
1 of 76 funds reported for Sep 30 · net +1.0K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
5.21% of float · ▲ +3.6% MoM · 12.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
76 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $26
Now $29 · 29%
Range high $38
vs 200-day avg -3%
vs 50-day avg +4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LKFT
this stock
Lakefront Biotherapeutics NV
|
$1.92B | -10.2% | — | — | 5.2% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$133.37B | +11.3% | +46.2% | 30.7 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.13B | -4.8% | +20.8% | 19.5 | 2.5% |
|
MRNA
Moderna, Inc.
|
$79.40B | +544.3% | +4.3% | — | 8.2% |
|
CSLLY
Csl Ltd
|
$61.25B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LKFT | 0.0% | +1.2% | +2.8% | -0.9% | -10.2% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | +0.2% | +1.7% | -9.3% | -1.9% | -23.0% |